Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CBP-4888 by Comanche Biopharma for Pre-Eclampsia: Likelihood of Approval
CBP-4888 is under clinical development by Comanche Biopharma and currently in Phase I for Pre-Eclampsia. According to GlobalData, Phase I...